J&J Snack Foods Corp. enters the first week of May with an interesting internal contradiction: the stock is up 7% over the past month, but short sellers have been quietly rebuilding positions throughout that rally.
Short interest has become the defining data point this week. It climbed to 5.1% of free float — up roughly 17% versus a month ago — after a sharp leg higher in mid-April. The move is particularly visible in the daily readings: SI held around 4.3% through early April, then jumped to nearly 5% between April 10 and April 13, and has held that elevated range since. The stock closed at $84.59 on May 5, off 2.6% on the week but well above its early-April lows. The combination of rising short interest alongside a recovering price tells a story of growing conviction on the bear side.
The borrow market, however, has materially eased and does not support aggressive short pressure. Cost to borrow dropped sharply to 0.43% — down nearly 40% over the week and 61% over the past month. That is close to the cheapest borrows have been in the data window, falling steadily from peaks of 1.3–1.5% seen in late March and early April. Availability remains loose, with borrow utilisation barely above 0.9% — well below its 52-week high of 11.4%. Cheap borrows and abundant supply mean there is no meaningful squeeze tension in the lending market right now, even as the absolute level of short interest edges higher.
Options positioning adds a different layer to the picture. Puts outnumber calls by a ratio of 2.67, running at roughly its 20-day average of 2.62 — the z-score of 0.34 implies this is normal rather than a defensive spike. For context, the 52-week PCR range runs from 0.06 all the way to 6.43, so current readings are unremarkable within that span. Options traders are not registering unusual alarm; the defensive tilt in the PCR is simply a structural feature of how this stock's options market tends to trade.
The Street picture is difficult to read clearly because the most recent analyst data is stale. The last recorded changes came from Benchmark in November 2025, when the firm trimmed its target to $130 from $150 while holding a Buy rating. Jefferies had lowered its target earlier in 2025 while maintaining Hold. The mean price target from that data sits around $110 — well above the current $84.59 close — but given how dated this information is, the gap should be treated with caution rather than as a reliable return signal. The ORTEX short score of 37.9 puts JJSF in the lower third of the universe on short-side pressure, consistent with a stock where bears are present but not dominant. The days-to-cover rank lands in the 81st percentile, reflecting the fact that at roughly 2.7 days to cover (per FINRA's fortnightly data), unwinding the short book is not a quick exercise.
Ownership is concentrated. Gerald Shreiber, the company's long-time chairman, holds nearly 19% of shares, with BlackRock and Vanguard each above 10%. That founder-heavy structure limits the float and amplifies the days-to-cover dynamic. The next scheduled catalyst is Q2 2026 results, though no confirmed date appears in the data. The sole post-earnings price reaction on record for the recent window shows a 2.8% drop the day after the May 4 release — a modest reaction, worth tracking as the market digests whatever came through in that print.
What to watch next: whether the short rebuild continues into the post-earnings period, and whether the borrow cost, which has been drifting lower all month, firms back up as a signal that demand for shorts is picking up again.
See the live data behind this article on ORTEX.
Open JJSF on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
